Global Protein Expression Market Research Report 2019-2023

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
41
Global Protein Expression Market Research Report 2019-2023 with Profiles of Agilent Technologies, Bio-Rad Labs, Merck, Promega., GenScript, Thermo Fisher Scientific, and Qiagen

Dublin, Feb. 12, 2019 (GLOBE NEWSWIRE) -- The "Protein Expression: Global Markets" report has been added to ResearchAndMarkets.com's offering.

This research report presents an in-depth analysis of the global market for protein expression by system type, products and services, applications, end users and regional markets. The report includes key protein expression systems that are incorporated in several therapeutic treatment methods.

It discusses the role of supply chain members from manufacturers to researchers. The report provides an in-depth analysis of key companies operating in the global market for protein expression. A patent analysis focuses on describing technological trends across periods of time and regions, such as the U.S., Europe and Japan. The protein expression market is mainly segmented into the following system types: prokaryotic expression systems, mammalian cell expression systems, insect cell expression systems, yeast expression systems, cell-free expression systems and algal-based expression systems. This market is further segmented based on products and services into reagents, expression vectors, competent cells, instruments and services. The market study details end users and applications, and ongoing activity in the research and development area. The market is segmented by region into North America, Europe, Asia-Pacific and the rest of the world (ROW).

Companies profiled in this report include Thermo Fisher Scientific Inc., Merck KGaA, Promega Corp., Agilent Technologies, GenScript, Takara Holdings Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Lonza and others. The Report Includes:

  • An overview and in-depth analysis of the global markets for protein expression technologies
  • Analyses of global market trends with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Discussion on perfusion approaches and supporting practices such as continuous biomanufacturing, and digital and model-based controls
  • Identification of key market dynamics and the factors impacting the global market for protein expression and its sub-segments
  • Regional dynamics of the global protein expression market and analysis of trends and opportunities in major regions covering North America, Europe, Asia-Pacific and the rest of the world (ROW)
  • A relevant patent analysis focuses on describing technological trends across periods of time and regions, such as the U.S., Europe and Japan
  • Detailed analysis of the cloning technologies, production of recombinant proteins and problems associated with protein production
  • Assessment of major stakeholders, product portfolios and recent developments and the competitive landscape among market leaders
  • Company profiles of leading global payers, including Agilent Technologies, Bio-Rad Laboratories Inc., Merck KGaA, Promega Corp., GenScript, Thermo Fisher Scientific Inc., and Qiagen N.V.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Market Definition
  • Protein Expression Market Overview
  • Choice of Cell Type
  • Choice of Plasmid
  • Choice of Cell Expression System
  • Introduction to Protein Expression Systems
  • Protein Synthesis Machinery
  • What is Protein Expression?
  • How Proteins Are Made
  • Transcription and Translation
  • Perfusion Approaches and Supporting Practices (e.g., Continuous BioManufacturing and Digital and Model-based Controls)
  • Post-translational Modification
  • Cloning Technologies
  • Constitutive and Inducible Promoters Commonly Used in Recombinant Protein Expression Systems
  • Production of Recombinant Proteins
  • Recombinant Protein Expression Methods
  • Why Produce Proteins Recombinantly?
  • Comparison of Expression Systems
  • Post-translational Processing
  • Problems Associated with the Production of Protein
  • Loss of Expression
  • Ongoing Clinical Trials for Protein Expression
  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunities

Chapter 4 Global Market for Protein Expression Systems by Type

  • Introduction
  • Constitutive and Inducible Promoters Commonly Used in Recombinant Protein Expression Systems
  • Characteristics of Various Recombinant Protein Expression Systems
  • Prokaryotic Expression Systems
  • Promoters
  • E. coli Systems
  • Other Prokaryotic Expression Systems
  • Mammalian Cell Expression Systems
  • Mammalian Expression Vectors Characteristics
  • Chinese Hamster Ovary (CHO) Systems
  • Other Mammalian Cell Systems
  • Insect Cell Expression Systems
  • Baculovirus Systems
  • Yeast Expression Systems
  • K. Lactis Systems
  • Saccharomyces Systems
  • Pichia Systems
  • Cell-Free Expression Systems
  • Algal-Based Expression Systems

Chapter 5 Global Market for Protein Expression by Products and Services

  • Overview
  • Reagents
  • Acids and Bases
  • Acrylamides
  • Buffers/Buffer Salts
  • Cell Lysis
  • Detergents
  • General Reagents
  • Labware
  • Protease Inhibitors
  • Solvents
  • Expression Vectors
  • Commonly Used Expression Hosts
  • Competent Cells
  • Instruments
  • Bioreactor Systems
  • Services
  • Protein Expression Services
  • Benefits
  • Specific Services Provided by Organizations

Chapter 6 Global Market for Protein Expression by Application

  • Introduction
  • Medicine
  • Research
  • Biotechnology
  • Therapeutic
  • Traditional Recombinant and Newer Cell Therapies including Stem Cell
  • Industrial
  • Research

Chapter 7 Global Market for Protein Expression by End User

  • Overview
  • Pharmaceutical and Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations
  • Others

Chapter 8 Global Market for Protein Expression by Region

Chapter 9 Government Regulations

  • General Manufacturing Guidelines
  • Control of Starting/Source Materials
  • Expression Vector and Host Cell
  • Cell Bank System
  • Cell Culture Medium/Other Materials
  • Control of the Manufacturing Process
  • Cell Culture
  • Purification
  • Control of Drug Substance and Drug Product
  • Characterization
  • Routine Control

Chapter 10 Patent Review

  • Patent Analysis
  • Patents and Patent Applications Filed by Institutions

Chapter 11 Competitive Landscape

  • Acquisition
  • Thermo Fisher Scientific Acquired Affymetrix
  • Product Launches

Chapter 12 Company Profiles

  • Abnova (Taiwan) Corp.
  • Accelagen Inc.
  • Agilent Technologies Inc.
  • Biomatik
  • Bio-Rad Laboratories Inc.
  • Domainex Ltd.
  • Enzo Life Sciences Inc.
  • Exon Biosystems
  • Genscript
  • Lonza Group Ag
  • Lucigen Corp.
  • Merck Kgaa
  • New England Biolabs Inc.
  • Novoprotein Scientific Inc.
  • Origene Technologies Inc.
  • Oxford Expression Technologies Ltd.
  • Promega Corp.
  • Proteogenix Inc.
  • Qiagen Inc.
  • R&D Systems Inc.
  • Sino Biological Inc.
  • Syngene
  • Synthetic Genomics Inc.
  • Takara Holdings, Inc.
  • Thermo Fisher Scientific Inc.

Chapter 13 Appendix: Uses of Protein Expressions Systems

For more information about this report visit https://www.researchandmarkets.com/research/k...otein?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Proteomics

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Nippon Steel and TIER IV Unite for Autonomous Steel Transport

Updated Category News Views 357

Innovative Partnership for Autonomous Steel Transportation Nippon Steel Corporation, known as Japan's largest steel manufacturer, has initiated a significant collaboration with TIER IV, Inc., a trailblazer in the development of open-source software for autonomous driving. This partnership is set to revolutionize the way steel is transported within manufacturing...

Continue Reading
Brock Group Expands Leadership with New Regional Units

Updated Category News Views 303

The Brock Group Expands Leadership with New Regional Units The Brock Group is taking significant strides in enhancing its Brock Industrial Services (BIS) division. Recently, the company announced the creation of two new regional operating units designed to bolster its service capabilities and responsiveness for customers nationwide. Under this new organizational...

Continue Reading
Exploring Demand for Nasdaq-100 Index in Retirement Plans

Updated Category News Views 178

Rising Interest in Nasdaq-100 Index for Retirement Investments Recent findings reveal a burgeoning interest in the Nasdaq-100 Index among retirement plan participants. This trend signifies a noteworthy opportunity for retirement investment options catering to the needs of a modern workforce. A recent survey indicated that nearly 80 percent of 401(k) plan participants...

Continue Reading
ModivCare Securities Lawsuit Update: Key Details for Investors

Updated Category News Views 132

Important Updates Regarding ModivCare Lawsuit Levi & Korsinsky, LLP is reaching out to investors who have been part of ModivCare Inc. (NASDAQ: MODV) regarding a pivotal class action securities lawsuit. This notification signals a chance for investors affected by the Company’s alleged securities fraud to seek compensation. Understanding the Class Action Lawsuit The...

Continue Reading
Key Details for Nordic Fibreboard AS Annual Meeting Announcement

Updated Category News Views 163

Essential Details for the Upcoming Annual General Meeting The Annual General Meeting (AGM) of Nordic Fibreboard AS (registry code: 11421437) will be convened to discuss pivotal matters affecting the company's future. Set to take place at the headquarters in Pärnu, Estonia, the AGM is a prime opportunity for shareholders to engage directly with the company's management...

Continue Reading